Clinical trials
Participation clinical trials
Below are recruiting participation clinical trials, each written for real people, not researchers. We’re tracking 2,283 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05822427Recruiting
Long-term follow-up for people who received azer-cel
This study checks how people do over a longer period after receiving azer-cel in an Imugene trial. It helps doctors understand long-term safety and health outcomes, even if you are feeling well now.
Culver City, CaliforniaAges 18 years+ - NCT07096193RecruitingPhase 1/Phase 2
Study of GS-4321 for chronic hepatitis delta
This trial tests a new drug, GS-4321, for people with chronic hepatitis delta, a serious liver infection. It aims to see if the drug is safe and effective, and compares results in healthy volunteers and those with the virus.
Anaheim, CaliforniaAges 18–69 - NCT07081503RecruitingPhase 1
Testing ADX-626 in healthy adults
This study tests a new investigational drug called ADX-626 in healthy volunteers for the first time in humans. The goal is to see how the drug is processed by the body and whether it is safe, helping to decide if it can be studied in future patients.
LondonAges 18–45 - NCT07079124Enrolling by invitation
Social program for older adults in nursing homes
This study tests a social participation program designed to help older adults who live in nursing homes stay connected and engaged. It may help you feel more active and involved in your community.
Fuzhou, FujianAges 60 years+ - NCT07071259Recruiting
Brain activity and structure study in healthy adults
This study looks at how your brain's electrical activity relates to its structure using safe, non-invasive techniques (TMS, EEG, and MRI). It's a chance to learn more about how the healthy brain works, and you'll be asked to have brain scans and a mild stimulation session.
MarseilleAges 18–35 - NCT06708520RecruitingPhase 1
Rupatadine safety study in people with kidney problems
This trial checks how the allergy medicine rupatadine moves through the body and how safe it is for people with different levels of kidney function, compared to people with healthy kidneys.
GaiaAges 18 years+ - NCT07024823RecruitingPhase 1
Safety study of AZD4248 in healthy people and those with kidney disease and diabetes
This trial tests an experimental drug called AZD4248 to see if it's safe for healthy people and for people with chronic kidney disease and type 2 diabetes. It also checks if a home device can accurately measure kidney function.
Glendale, CaliforniaAges 18–75 - NCT07023289RecruitingPhase 2
Study of Telisotuzumab Adizutecan for ctDNA-Positive Colorectal Cancer
This trial tests a new drug, Telisotuzumab Adizutecan, given through a vein (infusion) alone or with standard treatments for people with colorectal cancer who have no visible tumors on scans but still have cancer DNA (ctDNA) in their blood after surgery and chemotherapy.
Huntsville, AlabamaAges 18 years+ - NCT06588101Recruiting
Improving ICU family member trial participation
This trial tests different ways to help families of ICU patients join and stay in research studies. If you have a loved one in the ICU for more than 48 hours, you may be able to help find better ways to support families like yours.
Montreal, QuebecAges 18 years+ - NCT06945406RecruitingPhase 1
Study of an investigational drug for diabetes
This trial tests a new medicine, LY4057996, in people with type 1 or type 2 diabetes and in healthy volunteers. It aims to see if the drug is safe and how it works in the body.
NeussAges 18 years+ - NCT06930508Recruiting
Bringing HIV prevention meds to a family planning clinic
This study looks at offering HIV prevention medicines (PrEP) to patients visiting a family planning clinic. It aims to make it easier for people to access this care alongside their regular visit.
Providence, Rhode IslandAges 16 years+ - NCT06912295RecruitingPhase 1
Study of HL-1186 in healthy adults
This study tests a new medicine called HL-1186 in healthy volunteers to see how safe it is and how the body handles it. If you join, you will help researchers gather early information that may lead to future treatments.
WuxiAges 18–45 - NCT06917742RecruitingPhase 1
Study of CPTX2309 for rheumatoid arthritis and lupus
This trial tests an investigational drug called CPTX2309, given intravenously, for people with moderate to severe rheumatoid arthritis or systemic lupus erythematosus. It aims to see if the drug is safe and effective.
Herston, QueenslandAges 18–65 - NCT06912776Recruiting
Visual education tool for postpartum warning signs
This study tests a new visual education tool to help new mothers recognize and report urgent warning signs after childbirth. If you qualify, you'll learn how to spot symptoms that may need quick medical attention.
Chicago, IllinoisAges 18 years+ - NCT06911359RecruitingPhase 2
Anti-inflammatory vs. Prolotherapy for Knee Osteoarthritis
This study tests whether anti-inflammatory medications or dextrose prolotherapy (sugar water injections) can reduce knee pain and improve function in people with knee osteoarthritis. If you are a military healthcare beneficiary with moderate to severe knee pain, you may be able to join.
Travis AFB, CaliforniaAges 45–75 - NCT06888011Recruiting
Healthy living program for rural children
This study tests a program called iAmHealthy to help children ages 6 to 11 who live in rural areas and are overweight. The program will help families make healthy changes at home and in their daily routine.
Kansas City, KansasAges 6–11 - NCT06867107Enrolling by invitationPhase 2
Long-term follow-up study of SAT-3247 for Duchenne muscular dystrophy
This study follows people with Duchenne muscular dystrophy who were in an earlier SAT-3247 trial, or who meet certain other criteria, to see how the medicine works over a longer time. It aims to gather more safety and effectiveness information.
Los Angeles, CaliforniaAges 16–40 - NCT06821516Recruiting
Comparing two nerve blocks for hip replacement pain
This study compares two different nerve block techniques to manage pain after a total hip replacement. The goal is to find out which method provides better pain relief and recovery.
Istanbul, Türki̇yeAges 18 years+ - NCT06809400RecruitingPhase 1
Study of LY4006896 for Parkinson's disease
This study tests an investigational drug called LY4006896 in healthy people and in people with Parkinson's disease. It aims to see if the drug is safe and how it affects the body, which may help in developing a new treatment for Parkinson's.
Los Alamitos, CaliforniaAges 30–85 - NCT06780150Recruiting
Ocrelizumab effects on nerve health and satisfaction in MS
This study looks at how ocrelizumab treatment affects a nerve health marker called neurofilament light chain (NfL) and how satisfied you are with the treatment. It may help doctors understand if this medicine works well for people with multiple sclerosis.
AachenAges 18 years+ - NCT06671054RecruitingPhase 2
Testing AP1189 for newly diagnosed active rheumatoid arthritis
This study tests an oral drug called AP1189 for people just diagnosed with active rheumatoid arthritis who haven't yet taken standard arthritis medicines. You may be able to take part if your disease is very active and you're ready to try a new treatment option.
Cutler Bay, FloridaAges 18 years+ - NCT06665646RecruitingPhase 1
HIV vaccine booster study for previous trial participants
This study tests a booster vaccine for HIV in people who were part of an earlier HIV vaccine trial. The goal is to see if it's safe and helps the immune system fight HIV better.
San Francisco, CaliforniaAges 18–60 - NCT06649110RecruitingPhase 1/Phase 2
A study of LTP001 for healthy people and those with PAH
This study tests an investigational medicine called LTP001 for pulmonary arterial hypertension (PAH). Part A checks safety in healthy volunteers, and Part B tests if it helps people with PAH by improving blood flow in the lungs.
Scottsdale, ArizonaAges 18–100 - NCT06655870RecruitingPhase 1
Safety of an experimental drug in healthy volunteers
This trial tests a new experimental drug called mRNA-0184, given as an injection under the skin, to see if it is safe and well tolerated in healthy people. It is an early-phase study, so participants will help determine if the drug can move forward to larger trials.
Melbourne, VictoriaAges 18–55
Hear when a new Participation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for participation?
- Yes. Clin2 currently lists 2,283 recruiting participation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a participation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a participation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.